Achievements in R&D
News & Achievements
Proudly Recognized by DSIR
Advancing Pharma Innovation at Mendine
DSIR Accreditation Announcement – November 17, 2025
Pioneering R&D in Eastern India
Dr. Sreeparna Chakraborty – VP, Research & Development
Received on November 17, 2025, this recognition positions Mendine Pharmaceuticals Pvt Ltd among the few pharmaceutical companies in West Bengal and Eastern India with officially recognized R&D capabilities by DSIR.
Unlike the region’s traditionally manufacturing-focused pharma industry, Mendine stands apart through the integration of both research and production capabilities.
This dual strength strengthens Mendine’s ability to drive scientific innovation, advanced formulations, and improved healthcare solutions for the future.
Strategic Edge
Dr. Amitava Kabiraj – HOD, R&D
As an MSME pharmaceutical manufacturing unit, Mendine demonstrates remarkable agility by integrating cutting-edge R&D initiatives such as formulation development and process optimization directly with its production lines.
This synergy enables faster innovation cycles, import substitution, and continuous quality improvement — a rare capability among pharmaceutical MSMEs in Eastern India.
The DSIR accreditation also unlocks new opportunities including tax incentives, research funding, and strategic collaborations, further strengthening Mendine’s position as an emerging innovation leader in the pharmaceutical sector.
Key Benefits of DSIR Accreditation
- ✔ Eligibility for customs duty exemptions on R&D imports
- ✔ Access to weighted tax deductions
- ✔ Enhanced credibility for collaborations and research grants
- ✔ Strengthened intellectual property development
- ✔ Facilitated technology transfer and industry partnerships
